Abstracts
Showing 851 abstracts.
Citation
E. Richard Stiehm, M.D., Courtney V. Fletcher, Pharm.D., Lynne M. Mofenson, M.D., F.A.A.P. Human Hyperimmune HIV Intravenous Immunoglobulin (HVIG) In the Treatment Of HIV-1 Infected Children.Citation
Sandra K. Burchett, M.D., M.S., Margaret Khoury, M.D., Kenneth McIntosh, M.D., S. V. Carey, Rebecca Oyomopito, M.S., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Andrea Kovacs, M.D. Viral Load Reduction (VLR) In HIV-Infected Children With Advanced Disease Treated With 4-Drug ARV Regimens Including NRTIs, Nevirapine (NVP), Nelfinavir (NFV), and/or Ritonavir (RTV).Citation
Richard Brundage, Pharm.D., Ph.D., Mark W. Kline, M.D., Jane C. Lindsey, Sc.D., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D. Pharmacokinetics (PK) Of Saquinavir (SQV) and Nelfinavir (NFV) In A Twice-Daily (BID) Regimen In HIV-Infected Children.Citation
Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Lynne M. Mofenson, M.D., F.A.A.P., David E. Shapiro, Ph.D., Mary Glenn Fowler, M.D., M.P.H., Pamela J. Boyer, M.D. Reproductive Choices And Pregnancy Outcomes After Participation In ACTG 076.Citation
Coleen K. Cunningham, M.D., Joseph A. Church, M.D., Paul Palumbo, M.D., Prakash Sista, Ph.D., Michael Hughes, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Elaine Margaret Smith, M.D. Chronic subcutaneous T-20 in HIV-infected children: safety and antiviral activity.Study
P1005
Citation
William Borkowsky, M.D., Ram Yogev, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Elizabeth (Betsy) J. McFarland, M.D., Lisa M. Frenkel, M.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D. T-Cell and virologic outcomes of a progressively increasing structured treatment interruption (STI) study in chronically infected children and adolescents.Study
P1015